Dr Bildad Nyambura has joined Pharmaterials as Head of Inhalation. Bildad has a PhD from the School of Pharmacy, University of London, where he authored patents and research papers relating to pressurised metered dose and dry powder inhalers.
Bildad has worked in the inhalation field with GSK for several years before joining Pharmaterials and has experience in delivery of small and macromolecular actives.
Professor Graham Buckton, Pharmaterials CEO, said "Bildad has a wide range of experience in the inhalation field and this will be a very valuable resource for our customers. I am convinced that Bildad and the formulation team will assist in bringing many new chemical entities and generic formulations to market through the inhaled route". |
